1. Home
  2. Analysis
  3. Risperdal-consta
  4. Urinary-retention

Risperdal consta and Urinary retention - a phase IV clinical study of FDA data

Summary:

Urinary retention is reported as a side effect among people who take Risperdal consta (risperidone), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Clexane, and have Schizophrenia.

The phase IV clinical study analyzes which people have Urinary retention when taking Risperdal consta. It is created by eHealthMe based on reports of 17,030 people who have side effects when taking Risperdal consta from the FDA, and is updated regularly.

What is Risperdal consta?

Risperdal consta has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 17,116 Risperdal consta users. Check the latest studies of Risperdal consta.

What is Urinary retention?

Urinary retention (the inability to completely or partially empty the bladder) is found to be associated with 1,567 drugs and 1,741 conditions by eHealthMe. Check the latest studies of Urinary retention.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

17,030 people reported to have side effects when taking Risperdal consta.
Among them, 38 people (0.22%) have Urinary retention.

Could Risperdal consta cause Urinary retention?

Among these 38 people:

How long have people been on Risperdal consta when they have Urinary retention? *

  • < 1 month: 71.43 %
  • 1 - 6 months: 14.29 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 14.29 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Urinary retention when taking Risperdal consta? *

  • female: 28.95 %
  • male: 71.05 %

What is the age of people who have Urinary retention when taking Risperdal consta? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 3.12 %
  • 20-29: 3.12 %
  • 30-39: 6.25 %
  • 40-49: 15.62 %
  • 50-59: 53.12 %
  • 60+: 18.75 %

What are other drugs people take besides Risperdal consta? *

  1. Clexane: 13 people, 34.21%
  2. Risperdal: 11 people, 28.95%
  3. Atarax: 3 people, 7.89%
  4. Diazepam: 3 people, 7.89%
  5. Seroquel: 3 people, 7.89%
  6. Zyprexa: 2 people, 5.26%
  7. Oxybutynin: 2 people, 5.26%
  8. Akineton: 2 people, 5.26%
  9. Amlodipine: 2 people, 5.26%
  10. Lisinopril: 2 people, 5.26%

What are other side effects people have besides Urinary retention? *

  1. Urinary Tract Infection: 18 people, 47.37%
  2. Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 14 people, 36.84%
  3. Pneumonia: 13 people, 34.21%
  4. General Physical Health Deterioration (weak health status): 13 people, 34.21%
  5. Haemorrhage (bleeding): 13 people, 34.21%
  6. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 13 people, 34.21%
  7. Irritability: 13 people, 34.21%
  8. Heart Attack: 13 people, 34.21%
  9. Aggression: 13 people, 34.21%
  10. Poisoning: 12 people, 31.58%

What are the existing conditions these people have? *

  1. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 20 people, 52.63%
  2. Stress And Anxiety: 3 people, 7.89%
  3. Psychotic Disorder: 3 people, 7.89%
  4. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 5.26%
  5. Pain: 2 people, 5.26%
  6. Insomnia (sleeplessness): 2 people, 5.26%
  7. Blood Glucose Abnormal: 2 people, 5.26%
  8. Parkinson's Disease: 1 person, 2.63%
  9. Neoplasm Malignant (cancer tumour): 1 person, 2.63%
  10. Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Risperdal consta and have Urinary retention?

- Check whether Urinary retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Risperdal consta:

Urinary retention treatments and more:

How severe was Urinary retention and when was it recovered:

Expand to all the drugs that have ingredients of risperidone:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Risperdal consta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary retention:

Browse all the conditions that are associated with Urinary retention:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on risperidone (the active ingredients of Risperdal consta) and Risperdal consta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.